NCT06304883TerminatedPhase 3
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Long-term Extension of a Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study of the Efficacy, Safety, and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Reason given: Sponsor business decision
Brief summary (registry, in English)
This study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is an open-label trial of treatment with ALZ-801.
- Status (registry)
- Terminated
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 163 (actual)
- First submitted
- 5 Mar 2024
- Start date
- 2 Apr 2024
- Primary completion date
- 11 Mar 2026
- Lead sponsor
- Alzheon Inc.
- Diseases
- Alzheimer disease
- NCT number
- NCT06304883
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has received (or plans to receive) amyloid antibodies since completing Phase 3 core study (ALZ-801-AD301).
- Subject taking any prohibited medications per protocol.
Other illness
- Significant worsening of medical conditions that may preclude completion of this study.
Other
- Evidence of symptomatic or new moderate-severe radiologic ARIA at baseline.
Who the study is looking for
- Subject has completed the Week 78 of the Phase 3 core study (ALZ-801-AD301) while on study drug.
- Subject has a reliable study partner who has sufficient contact with the subject to be able to provide accurate information about the subject's cognitive and functional abilities.
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (41)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centricity Research | Halifax | Canada | Unknown status |
| OCT Research ULC (dba Okanagan Clinical Trials) | Kelowna | Canada | Unknown status |
| Recherches Neuro-Hippocampe, Inc., d/b/a Ottawa Memory Clinic | Ottawa | Canada | Unknown status |
| Kawartha Centre - Redefining Healthy Aging | Peterborough | Canada | Unknown status |
| Toronto Memory Program | Toronto | Canada | Unknown status |
| Re-Cognition Health Ltd Birmingham | Birmingham | United Kingdom | Unknown status |
| Re:Cognition Health Ltd Bristol | Bristol | United Kingdom | Unknown status |
| Re-Cognition Health Ltd Guildford | Guildford | United Kingdom | Unknown status |
| Re:Cognition Health Ltd (London) | London | United Kingdom | Unknown status |
| NeuroClin Glasgow Ltd | Motherwell | United Kingdom | Unknown status |
| Re-Cognition Health Ltd Plymouth | Plymouth | United Kingdom | Unknown status |
| Re-Cognition Health Ltd Winchester | Winchester | United Kingdom | Unknown status |
| Abington Neurological Associates | Abington | United States | Unknown status |
| Neurological Associates of Albany | Albany | United States | Unknown status |
| JEM Research Institute, Headlands Site | Atlantis | United States | Unknown status |
| Northwest Clinical Research Center | Bellevue | United States | Unknown status |
| Columbus Memory Center | Columbus | United States | Unknown status |
| ATP Clinical Research | Costa Mesa | United States | Unknown status |
| Rhode Island Mood & Memory Research Institute | East Providence | United States | Unknown status |
| Re:Cognition Health | Fairfax | United States | Unknown status |
| Fort Wayne Neurological Center | Fort Wayne | United States | Unknown status |
| Triad Clinical Trials | Greensboro | United States | Unknown status |
| UT Health Science Center at Houston | Houston | United States | Unknown status |
| Torrance Clinical Research Institute | Lomita | United States | Unknown status |
| K2 Medical Research, LLC | Maitland | United States | Unknown status |
| AMC Research | Matthews | United States | Unknown status |
| Mount Sinai Medical Center | Miami Beach | United States | Unknown status |
| Aqualane Clinical Research | Naples | United States | Unknown status |
| NYU Alzheimer's Disease Research Center | New York | United States | Unknown status |
| Charter Research | Orlando | United States | Unknown status |
| Xenoscience Inc. | Phoenix | United States | Unknown status |
| Headlands Research - Eastern MA | Plymouth | United States | Unknown status |
| Center for Cognitive Health | Portland | United States | Unknown status |
| Progressive Medical Research | Port Orange | United States | Unknown status |
| University of Rochester Medical Center | Rochester | United States | Unknown status |
| Sutter Health | Sacramento | United States | Unknown status |
| ALZ Research and Treatment Center (A.R.T.C.) | Stuart | United States | Unknown status |
| Banner Sun Health Research Institute | Sun City | United States | Unknown status |
| Advanced Memory Research Center | Toms River | United States | Unknown status |
| ALZ Research and Treatment Center (A.R.T.C.) | Wellington | United States | Unknown status |
| Premiere Research Institute | West Palm Beach | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.